Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis.
作者信息
Evora Paulo Roberto B
机构信息
Department of Surgery and Anatomy, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
出版信息
Tex Heart Inst J. 2016 Feb 1;43(1):103. doi: 10.14503/THIJ-15-5629. eCollection 2016 Feb.
Abstract
摘要
相似文献
1
Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis.
Tex Heart Inst J. 2016 Feb 1;43(1):103. doi: 10.14503/THIJ-15-5629. eCollection 2016 Feb.
2
To the Editor.
Tex Heart Inst J. 2016 Feb;43(1):103.
3
A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Tex Heart Inst J. 2015 Oct 1;42(5):491-4. doi: 10.14503/THIJ-14-4470. eCollection 2015 Oct.
4
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1519-25. doi: 10.1586/erc.11.160.
5
Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
A A Case Rep. 2015 Oct 15;5(8):127-30. doi: 10.1213/XAA.0000000000000190.
6
Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration.
Ann Thorac Surg. 2019 Jan;107(1):e57. doi: 10.1016/j.athoracsur.2018.07.052. Epub 2018 Sep 21.
7
Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.
J Thorac Cardiovasc Surg. 2004 Mar;127(3):895-6; author reply 896. doi: 10.1016/j.jtcvs.2003.09.046.
8
Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
J Thorac Cardiovasc Surg. 2003 Jun;125(6):1426-31. doi: 10.1016/s0022-5223(02)73284-4.
9
Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
Med Sci Monit. 2012 May;18(5):HY13-7. doi: 10.12659/msm.882718.
10
Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery.
Can J Cardiol. 2003 Feb;19(2):167-9.
引用本文的文献
1
Nitroglycerin-responsive gene switch for the on-demand production of therapeutic proteins.
Nat Biomed Eng. 2025 Feb 14. doi: 10.1038/s41551-025-01350-7.
2
Supermicrosurgical Vascular Anastomosis-A Comparative Study of Lumen-Enhancing Visibility Techniques.
J Clin Med. 2025 Jan 16;14(2):555. doi: 10.3390/jcm14020555.
3
Application of methylene blue for the prevention and treatment of COVID-19: A narrative review.
Iran J Basic Med Sci. 2024;27(7):780-792. doi: 10.22038/IJBMS.2024.71871.15617.
4
Methylene blue for the treatment of refractory septic shock secondary to listeriosis in a paediatric patient.
BMJ Case Rep. 2022 Feb 28;15(2):e243772. doi: 10.1136/bcr-2021-243772.
5
Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study.
J Clin Med. 2022 Feb 20;11(4):1121. doi: 10.3390/jcm11041121.
6
Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations.
Biomed Pharmacother. 2021 Oct;142:112023. doi: 10.1016/j.biopha.2021.112023. Epub 2021 Aug 10.
7
The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders.
Redox Biol. 2020 Jul;34:101567. doi: 10.1016/j.redox.2020.101567. Epub 2020 May 15.
8
Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies.
Int J Mol Sci. 2019 Oct 11;20(20):5034. doi: 10.3390/ijms20205034.
9
Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.
Int J Mol Sci. 2019 Aug 16;20(16):4002. doi: 10.3390/ijms20164002.
10
An ATR-FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ.
ACS Med Chem Lett. 2017 Jun 11;8(7):710-714. doi: 10.1021/acsmedchemlett.7b00079. eCollection 2017 Jul 13.
本文引用的文献
1
A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Tex Heart Inst J. 2015 Oct 1;42(5):491-4. doi: 10.14503/THIJ-14-4470. eCollection 2015 Oct.
2
Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.
Rev Bras Cir Cardiovasc. 2015 Jan-Mar;30(1):84-92. doi: 10.5935/1678-9741.20140115.
3
Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
Rev Bras Cir Cardiovasc. 2009 Jul-Sep;24(3):279-88. doi: 10.1590/s0102-76382009000400005.
4
Inhibition of nitric oxide synthesis by methylene blue.
Biochem Pharmacol. 1993 Jan 26;45(2):367-74. doi: 10.1016/0006-2952(93)90072-5.
Zotero 插件